
Pharmaceutical R&D firm, Solaris Pharma, specializes in generic and specialty products.
Founded with a mission to innovate in the pharmaceutical industry, Solaris Pharma Corporation focuses on the development and marketing of high-quality, complex generic and specialty pharmaceutical products. The company operates a fully equipped Research & Development facility, leveraging its expertise to bring advanced healthcare solutions to the market. Solaris Pharma aims to address unmet medical needs and improve patient outcomes through its diverse product portfolio.
Notable figures affiliated with Solaris Pharma include experienced professionals in pharmaceutical research and development. The company has achieved significant milestones in the approval and commercialization of several complex generic medications, contributing to more accessible healthcare options. Solaris Pharma's impact is marked by its commitment to quality and innovation, positioning it as a key player in the specialty pharmaceutical sector.

Saptalis Pharmaceuticals

Bionpharma
bionpharma.com

Pyros Pharmaceuticals
pyrospharma.com

6S Pharma
6spharma.com

Sun Pharmaceutical Industries

Meitheal Pharmaceuticals
meithealpharma.com

Vertice Pharma

Leading Pharma
leadingpharma.com

Vitruvias Therapeutics
vitruvias.com

China PharmaHub

Scienture
scienture.com

Auxilius Pharma
auxiliuspharma.com

Manhattan Pharmaceuticals

Coeptis Pharmaceuticals

Concours Pharmaceuticals
Companies similar to Solaris Pharma include Saptalis Pharmaceuticals, Bionpharma, Pyros Pharmaceuticals and 6S Pharma.
Solaris Pharma was founded in 2014.
Solaris Pharma's headquarters is located in Bridgewater Township, NJ, US.
Solaris Pharma's most recent funding round was for $10M (USD) in December 2019.
As of Dec 9, 2019, Solaris Pharma has raised a total of $23.4M (USD).
Solaris Pharma has 31 employees as of Feb 5, 2024.